| Primary |
| Diabetes Mellitus |
56.5% |
| Diabetes Mellitus Non-insulin-dependent |
26.1% |
| Cough |
8.7% |
| Constipation |
4.3% |
| Essential Hypertension |
4.3% |
|
| Hypoglycaemia |
12.5% |
| Hypoglycaemic Coma |
12.5% |
| Syncope |
12.5% |
| Cerebral Infarction |
8.3% |
| Loss Of Consciousness |
8.3% |
| White Blood Cell Count Decreased |
8.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.2% |
| Hallucination |
4.2% |
| Nasopharyngitis |
4.2% |
| Nausea |
4.2% |
| Pneumonia Aspiration |
4.2% |
| Pulmonary Embolism |
4.2% |
| Respiratory Rate Increased |
4.2% |
| Sopor |
4.2% |
| Tremor |
4.2% |
|
| Secondary |
| Hypertension |
26.0% |
| Diabetes Mellitus |
24.0% |
| Drug Use For Unknown Indication |
8.3% |
| Acute Myocardial Infarction |
5.8% |
| Rheumatoid Arthritis |
5.8% |
| Gastric Ulcer |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Thrombosis Prophylaxis |
2.9% |
| Cellulitis |
2.5% |
| Cough |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Influenza |
2.1% |
| Antiinflammatory Therapy |
1.7% |
| Prophylaxis |
1.7% |
| Cardiac Failure |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Pain |
1.2% |
| Arteriosclerosis |
0.8% |
| Candidiasis |
0.8% |
| Cardiac Failure Congestive |
0.8% |
|
| Hypoglycaemia |
17.3% |
| Interstitial Lung Disease |
17.3% |
| Subcutaneous Haematoma |
9.6% |
| Toxic Epidermal Necrolysis |
9.6% |
| White Blood Cell Count Increased |
9.6% |
| Glycosylated Haemoglobin Increased |
3.8% |
| Lymphocyte Stimulation Test Positive |
3.8% |
| Medication Error |
3.8% |
| Staphylococcal Infection |
3.8% |
| Cerebral Infarction |
1.9% |
| Enterocolitis |
1.9% |
| Haematuria |
1.9% |
| Hepatic Enzyme Increased |
1.9% |
| Hypoglycaemic Encephalopathy |
1.9% |
| Loss Of Consciousness |
1.9% |
| Metabolic Acidosis |
1.9% |
| Occult Blood Positive |
1.9% |
| Pancreatitis |
1.9% |
| Purulence |
1.9% |
| Pyrexia |
1.9% |
|
| Concomitant |
| Hypertension |
26.3% |
| Diabetes Mellitus |
23.9% |
| Rheumatoid Arthritis |
7.0% |
| Drug Use For Unknown Indication |
5.8% |
| Type 2 Diabetes Mellitus |
4.7% |
| Hyperlipidaemia |
4.0% |
| Prophylaxis |
2.9% |
| Product Used For Unknown Indication |
2.8% |
| Angina Pectoris |
2.7% |
| Gastritis |
2.7% |
| Gastric Ulcer |
2.3% |
| Constipation |
2.1% |
| Hiv Infection |
2.0% |
| Premedication |
2.0% |
| Large Intestine Carcinoma |
1.8% |
| Diabetes Mellitus Non-insulin-dependent |
1.7% |
| Cerebral Infarction |
1.6% |
| Hypercholesterolaemia |
1.4% |
| Diabetic Neuropathy |
1.3% |
| Atrial Fibrillation |
1.2% |
|
| Vomiting |
11.0% |
| Hepatic Function Abnormal |
7.6% |
| Pneumonia |
6.9% |
| Hypoglycaemia |
6.2% |
| Eosinophil Count Increased |
5.5% |
| Hyperkalaemia |
5.5% |
| Cerebral Infarction |
4.8% |
| Interstitial Lung Disease |
4.8% |
| Loss Of Consciousness |
4.8% |
| Rhabdomyolysis |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Liver Disorder |
4.1% |
| Renal Failure Acute |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Cardiac Failure |
3.4% |
| Constipation |
3.4% |
| Nausea |
3.4% |
| Pain In Extremity |
3.4% |
| Photophobia |
3.4% |
| Toxic Skin Eruption |
3.4% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
75.0% |
| Hypertension |
25.0% |
|
|
